2nd INTERNATIONAL CONFERENCE ON THE USE OF HUMANE ENDPOINTS IN ANIMAL EXPERIMENTS FOR BIOMEDICAL RESEARCH
Presentations
Session I: The importance of general and specific clinical signs
for determining humane endpoints.
Careful monitoring of animals for the determination of humane endpoints:
D.B. Morton
CCAC guidelines on: choosing an appropriate endpoint in experiments using animals for research, teaching and testing:
G. Griffin, C. Gauthier
Humane endpoints and research in fish
K.Ryder
The Use of Humane Endpoints in chickens:
E.R.O.M.Hanenberg
Session II: Humane Endpoints in Cancer Research.
Hidden cancers and humane endpoints:
L.Rud, M.K.Larsen,
M.Ritskes-Hoitinga
Application of Humane Endpoints in Cancer Research:
J.Wallace
Session III: Application of Humane end points in practice.
Obstacles in the implementation of humane endpoints:
C.F.M.Hendriksen
Humane endpoints in biomedical research: an interactive CD ROM:
I.Boumans
Stress - assessed by quantification of non-invasive stress markers:
J.Hau
, K.S.Abelson, H.-E.Carlsson, F.Royo
Radio-Telemetry: A tool in humane endpoint determination?:
R.Remie
Humane Endpoints: Experiences of the UK Home Office Inspectorate:
D.Fry
The Importance of Animal Welfare Officers and the Commission according to Article 15 of the German Animal Welfare Act regarding Human Endpoints:
H.Ratsch
Session IV: Toxicology & Pharmacology
Thoughts of hope and reality concerning humane endpoints:
H.Koeter
Humane Endpoints for Animals Used in Biomedical Research and Testing: Best Practices,Policies, and Progress in the U.S.:
B.Stokes
Criteria and decision-making process for anticipating endpoints on preclinical development studies:
P.Guittin
Ch.Bouin, P.Gallix
Urinary biomarkers as non-invasive toxicological endpoints - recent advances:
R.Poon
Humane Endpoints and 3R-principles in the Quality Control of Human Pharmaceuticals and Vaccines:
J.Descamps
In Ovo Models for Tissue Engineering: Proposal to Use an Early Endpoint in the HET-CAM Test:
E.Falkner
, C.Eder, H.Appl, M.Mickel, U.M.Losert, H.Schöffl
Session V: Microbiology & Vaccine Testing
Animals in Infectious Disease Research – Balancing Welfare, Humane Endpoints and Valid Scientific Outcomes:
E.D.Olfert
Impediments to Humane Endpoints in Infectious Disease Research:
K.Andrutis
, A.Karas
Refinement of the Canine Leptospirosis Vaccine Potency Test: Experiences and Observations:
N.Reed
Application of humane endpoints in veterinary vaccine testing in target species:
L.Bruckner
Humane endpoints upon in vivo characterization of candidate third generation smallpox vaccine:
Y.Süzer
, C.Staib, S.Kisling, G.Sutter
August 20-21, 2005
Federal Institute for Risk Assessment (BfR),
Berlin, Germany